Literature DB >> 15334319

Axonal neuropathy and hearing loss associated with alpha interferon treatment in chronic hepatitis B: a case report.

Ayşe Tunca1, Mustafa Erbayrak, Sirin Aytaç, Cansel Türkay.   

Abstract

The effect of interferon alpha in chronic viral hepatitis and common side effects are well known, but axonal polyneuropathy and hearing loss have been rarely reported. A 58-year-old woman was administered interferon alpha-2a (9 MU/3 times a week) and lamividin (100 mg daily) with the diagnosis of chronic hepatitis B. At the fifth month of the treatment gait disturbance and tinnitus developed. In her neurological examination tandem gait was ataxic on the right side. Cerebral magnetic resonance imaging performed to elucidate a probable cerebral pathology revealed nonspecific millimetric hyperintense lesions thought to be related with her hypertension anamnesis. Electroneuromyography demonstrated mild axonal polyneuropathy. The finding of pure-tone audiometry was sensorineural hearing loss in her left ear. Our diagnosis was axonal polyneuropathy and sensorineural type hearing loss as a side effect of interferon. In conclusion, the development of polyneuropathy and sensorineural hearing loss in the same patient may suggest autoimmunity as the cause of these side effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334319

Source DB:  PubMed          Journal:  Turk J Gastroenterol        ISSN: 1300-4948            Impact factor:   1.852


  9 in total

1.  Unilateral hearing loss due to pegylated interferon-α2b and ribavirin therapy.

Authors:  Savita Jain; Vandana Midha; Ajit Sood
Journal:  Indian J Gastroenterol       Date:  2011-09

2.  Side effects of interferon-alpha therapy.

Authors:  Stefan Sleijfer; Marjolein Bannink; Arthur R Van Gool; Wim H J Kruit; Gerrit Stoter
Journal:  Pharm World Sci       Date:  2005-12

3.  Effect of interferon treatment on hearing of patients with chronic hepatitis C.

Authors:  Abdulrahman Hagr; Dima Jamjoom; Faisal M Sanai; Waleed Al Hamoudi; Ayman A Abdo; Ahmed Al-Arfaj
Journal:  Saudi J Gastroenterol       Date:  2011 Mar-Apr       Impact factor: 2.485

4.  Sudden hearing loss associated with peginterferon and ribavirin combination therapy during hepatitis C treatment.

Authors:  Hela Elloumi; Fatma Houissa; Najet-Bel Hadj; Dalila Gargouri; Malika Romani; Jamel Kharrat; Abdeljabbar Ghorbel
Journal:  World J Gastroenterol       Date:  2007-10-28       Impact factor: 5.742

5.  A case of hearing loss associated with pegylated interferon and ribavirin treatment ameliorated by prednisone.

Authors:  Vu Le; Ted Bader; Javid Fazili
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2008-11-25

6.  Bell's palsy during interferon alpha 2a treatment in a case with Behçet uveitis.

Authors:  Fatime Nilüfer Yalçindağ; Cem Alay
Journal:  F1000Res       Date:  2013-11-15

7.  Analysis of drug-induced hearing loss by using a spontaneous reporting system database.

Authors:  Mizuki Tanaka; Shiori Hasegawa; Satoshi Nakao; Kazuyo Shimada; Ririka Mukai; Kiyoka Matsumoto; Mitsuhiro Nakamura
Journal:  PLoS One       Date:  2019-10-08       Impact factor: 3.240

8.  INF- α and ototoxicity.

Authors:  Mohammad Reza Sharifian; Shima Kamandi; Hamid Reza Sima; Mohammad Ali Zaringhalam; Mehdi Bakhshaee
Journal:  Biomed Res Int       Date:  2013-07-25       Impact factor: 3.411

9.  Assessment of auditory functions in chronic hepatitis C patients treated by sofosbuvir.

Authors:  Elshahat Ibrahem Ismail; Ashraf Elsayed Morgan; Raghda Elsayed Farag
Journal:  J Otol       Date:  2017-12-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.